Elexacaftor/tezacaftor/ivacaftor treatment is associated with epigenetic age deceleration in cystic fibrosis
Josh P Dyce, Ana I. Hernández Cordero, Michael Steffen Kobor…·Bradley S. Quon
This study shows that ETI treatment in CF patients reduces epigenetic age acceleration, linked to inflammation and disease activity.